Writing the summary…
Astronomers just found the youngest known planet ever
Original reporting
Science Daily: read the full reportRelated stories
JWST’s mysterious little red dots may be black holes growing at incredible speeds
New supercomputer simulations suggest JWST’s puzzling Little Red Dots are rapidly growing black holes from the early Universe. Extreme radiation may have helped create unusually massive black hole seeds, while dense surrounding gas allowed them to grow dozens of times faster than black holes can today. The simulated objects closely resemble the Little Red Dots seen by Webb. If correct, they could solve the mystery of how enormous black holes formed so soon after the Big Bang.
Textbooks may have misdrawn this basic brain structure for 100 years
Scientists discovered that brain-cell axons may not be smooth tubes as textbooks have shown for more than a century, but instead naturally resemble strings of tiny pearls. Those pearl-like structures can change with neural activity and may help control how quickly electrical signals travel through the brain.

The farmer who turned to singing after bovine TB silenced his fields
Dairy farmer Mervyn Kelso struggled with the sadness of the empty fields when he lost his entire herd to bovine TB.

Why reshaping memories may hold the key to raising self-esteem
In a new book, psychologist Marisa Franco explains why it's good to feel good about yourself — and shares a helpful memory technique that we've turned into a printable worksheet.
Federal budget cuts may force some states to end meal delivery for Medicaid patients
Some states deliver meals to Medicaid patients that address their dietary needs. Evidence shows it aids recovery and saves healthcare costs, but federal budget cuts may lead some states to cancel it.
New mesothelioma drug turns cancer’s own defenses against it
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could eventually be used against other cancers.